{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:28:58Z","timestamp":1787668138597,"version":"build-2736575974"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.15499","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T15:02:38Z","timestamp":1654700558000},"page":"e2215499","source":"Crossref","is-referenced-by-count":21,"title":["Rates of Response to Atogepant for Migraine Prophylaxis Among Adults"],"prefix":"10.1001","volume":"5","author":[{"given":"Richard B.","family":"Lipton","sequence":"first","affiliation":[{"name":"Department of Neurology, Albert Einstein College of Medicine and the Montefiore Headache Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[{"name":"Headache Unit, Neurology Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"Headache Research Group, Vall d'Hebron Institute of Research, Universitat Autonoma of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Blumenfeld","sequence":"additional","affiliation":[{"name":"The San Diego Headache Center and The Los Angeles Headache Center, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McAllister","sequence":"additional","affiliation":[{"name":"New England Institute for Neurology and Headache, Stamford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Lu","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Dabruzzo","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Miceli","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Severt","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Finnegan","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Trugman","sequence":"additional","affiliation":[{"name":"AbbVie, Madison, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"zoi220454r1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/physiol.2013.75.issue-1","article-title":"Pathophysiology of migraine.","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"zoi220454r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition.","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"issue":"10283","key":"zoi220454r3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","article-title":"Migraine: epidemiology and systems of care.","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"zoi220454r4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","article-title":"Recommendations for headache service organisation and delivery in Europe.","volume":"12","author":"Steiner","year":"2011","journal-title":"J Headache Pain"},{"issue":"3","key":"zoi220454r5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/head.v61.3","article-title":"The migraine signature study: methods and baseline results.","volume":"61","author":"Pressman","year":"2021","journal-title":"Headache"},{"issue":"1","key":"zoi220454r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/head.13456","article-title":"The American Headache Society position statement on integrating new migraine treatments into clinical practice.","volume":"59","author":"American Headache Society","year":"2019","journal-title":"Headache"},{"issue":"17","key":"zoi220454r7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"zoi220454r9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0333102416678382","article-title":"Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis.","volume":"37","author":"Hepp","year":"2017","journal-title":"Cephalalgia"},{"issue":"4","key":"zoi220454r10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/head.2013.53.issue-4","article-title":"Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II).","volume":"53","author":"Blumenfeld","year":"2013","journal-title":"Headache"},{"issue":"1","key":"zoi220454r11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jan.2019.75.issue-1","article-title":"The fear of needles: a systematic review and meta-analysis.","volume":"75","author":"McLenon","year":"2019","journal-title":"J Adv Nurs"},{"issue":"9","key":"zoi220454r13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(20)30234-9","article-title":"Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b\/3 trial.","volume":"19","author":"Goadsby","year":"2020","journal-title":"Lancet Neurol"},{"issue":"8","key":"zoi220454r14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the preventive treatment of migraine.","volume":"385","author":"Ailani","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi220454r15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/0333102418758283","article-title":"Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.","volume":"38","author":"Tassorelli","year":"2018","journal-title":"Cephalalgia"},{"issue":"2","key":"zoi220454r16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/head.v61.2","article-title":"Systematic review of outcomes and endpoints in preventive migraine clinical trials.","volume":"61","author":"McGinley","year":"2021","journal-title":"Headache"},{"issue":"10","key":"zoi220454r17","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/head.v60.10","article-title":"Migraine headache day response rates and the implications to patient functioning: an evaluation of 3 randomized phase 3 clinical trials of galcanezumab in patients with migraine.","volume":"60","author":"Ford","year":"2020","journal-title":"Headache"},{"issue":"4","key":"zoi220454r18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/sim.v28:4","article-title":"A graphical approach to sequentially rejective multiple test procedures.","volume":"28","author":"Bretz","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"zoi220454r19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0333102419894559","article-title":"The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving =50%, =75%, and 100% response.","volume":"40","author":"Brandes","year":"2020","journal-title":"Cephalalgia"},{"issue":"1","key":"zoi220454r20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10194-020-01212-4","article-title":"Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.","volume":"22","author":"Silberstein","year":"2021","journal-title":"J Headache Pain"},{"key":"zoi220454r21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7525-2-32","article-title":"Patients\u2019 needs, satisfaction, and health related quality of life: towards a comprehensive model.","volume":"2","author":"Asadi-Lari","year":"2004","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"zoi220454r22","doi-asserted-by":"publisher","DOI":"10.2196\/13029","article-title":"Perceived treatment satisfaction and effectiveness facilitators among patients with chronic health conditions: a self-reported survey.","volume":"9","author":"Volpicelli Leonard","year":"2020","journal-title":"Interact J Med Res"},{"key":"zoi220454r8","year":"2021"},{"key":"zoi220454r12","year":"2021"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2793155\/lipton_2022_oi_220454_1654027892.567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T15:02:40Z","timestamp":1654700560000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2793155"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15499","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]}}}